Page 427 - Read Online
P. 427

Klaas et al. J Cancer Metastasis Treat 2023;9:23                   Journal of Cancer
               DOI: 10.20517/2394-4722.2022.125
                                                                       Metastasis and Treatment




               Review                                                                        Open Access



               Advanced breast cancer metastasized in the brain:
               treatment standards and innovations


               Elizabeth Klaas, Eric Sung, Esaan Azizi, Melanie Martinez, Arnav Barpujari, Jeffery Roberts, Brandon
               Lucke-Wold
               Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA.
               Correspondence to: Dr. Brandon Lucke-Wold, Department of Neurosurgery, University of Florida, 1505 SW Archer Rd.
               Gainesville, FL 32608, USA. E-mail: Brandon.Lucke-Wold@neurosurgery.ufl.edu

               How to cite this article: Klaas E, Sung E, Azizi E, Martinez M, Barpujari A, Roberts J, Lucke-Wold B. Advanced breast cancer
               metastasized in the brain: treatment standards and innovations. J Cancer Metastasis Treat 2023;9:23.
               https://dx.doi.org/10.20517/2394-4722.2022.125
               Received: 4 Nov 2022   First Decision: 2 Feb 2023  Revised: 20 Apr 2023   Accepted: 5 Jun 2023  Published: 14 Jun 2023

               Academic Editors: Zohreh Amoozgar; Christos A. Papadimitriou  Copy Editor: Fangling Lan   Production Editor: Fangling Lan

               Abstract
               Breast cancer continues to be a difficult disease to treat due to high rates of metastasis. Metastasis to the brain
               presents a unique and often overlooked challenge. In this focused review, we discuss the epidemiology of breast
               cancer and which types frequently metastasize to the brain. Novel treatment approaches are highlighted with
               supporting scientific evidence. The role of the blood-brain barrier and how it may become altered with metastasis
               is addressed. We then highlight new innovations for Her2-positive and triple-negative breast cancer. Finally, recent
               directions  for  luminal  breast  cancer  are  discussed.  This  review  serves  to  enhance  understanding  of
               pathophysiology, spark continued innovation, and provide a user-friendly resource through tables and easy-to-
               process figures.
               Keywords: Breast cancer, innovation, blood-brain barrier, luminal metastasis, new directions




               INTRODUCTION
               Over the last 25 years, the incidence and mortality of breast cancer has been tremendously increased
                        [1]
               worldwide . Breast cancer is the most diagnosed cancer in females, with approximately 2.3 million cases
               and over 680,000 deaths recorded in 185 countries, and is the second leading cause of cancer-related death







                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                           www.jcmtjournal.com
   422   423   424   425   426   427   428   429   430   431   432